{"id":83934,"topic":"peptides","source":"AllSci","title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","url_hash":"6ecf9150c49217ef72a8f05ce797786c23c99639","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","content":null,"image_url":null,"lang":"en","published_at":"2026-09-16T16:25:57+00:00","fetched_at":"2026-09-16T17:15:10+00:00","status":"read","starred":0,"extract_state":"failed","summary_auto":null,"cluster_id":null,"extract_retries":2,"extract_error":"trafilatura_none","contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}},"news_item":{"id":83934,"canonical_url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","source_url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","source_name":"AllSci","author":null,"published_at":"2026-09-16T16:25:57+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","full_text":null,"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","summary":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","source":"AllSci","date":"2026-09-16T16:25:57+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/83934","export_markdown":"/api/items/83934/export?format=markdown","export_json":"/api/items/83934/export?format=json","diagnose":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/"},"formats":{"full":{"id":83934,"title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","source":"AllSci","author":null,"published_at":"2026-09-16T16:25:57+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","full_text":null,"reading_time_min":1,"extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}},"actions":{"read":"/item/83934","export_markdown":"/api/items/83934/export?format=markdown","export_json":"/api/items/83934/export?format=json","diagnose":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/"}},"digest":{"id":83934,"title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","source":"AllSci","topic":"peptides","published_at":"2026-09-16T16:25:57+00:00","excerpt":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\"…","quality_bucket":"low","quality_reason":"Low confidence: extractor returned no usable article text.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","subtitle":"AllSci · 2026-09-16","summary":"<a…","badges":["quality:low","issue:extractor_empty"],"links":{"read":"/item/83934","original":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","diagnose":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/"},"quality_warning":"Low confidence: extractor returned no usable article text."},"export":{"title":"Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci","url":"https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","summary":"<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5\" target=\"_blank\">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AllSci</font>","source":"AllSci","date":"2026-09-16T16:25:57+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":426,"usable_text_length":426,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":426}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}